AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 143 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 6.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,302,924 | -88.2% | 51,055 | -95.8% | 0.00% | -90.5% |
| Q4 2023 | $11,003,325 | -14.6% | 1,215,837 | -39.8% | 0.02% | -19.2% |
| Q3 2023 | $12,886,898 | -41.7% | 2,019,890 | +1.4% | 0.03% | -46.9% |
| Q2 2023 | $22,100,529 | +91.5% | 1,992,834 | +165.0% | 0.05% | +69.0% |
| Q1 2023 | $11,541,880 | -19.8% | 751,914 | +15.9% | 0.03% | -25.6% |
| Q4 2022 | $14,397,449 | +1441.5% | 648,826 | +1034.2% | 0.04% | +1200.0% |
| Q3 2022 | $934,000 | -65.6% | 57,207 | -69.4% | 0.00% | -66.7% |
| Q2 2022 | $2,713,000 | -29.6% | 186,702 | +19.6% | 0.01% | -50.0% |
| Q2 2021 | $3,856,000 | – | 156,047 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 503,504 | $20,568,138 | 15.61% |
| Casdin Capital, LLC | 2,084,841 | $85,165,755 | 6.53% |
| COWEN AND COMPANY, LLC | 5,129,103 | $209,523,857 | 5.76% |
| RTW INVESTMENTS, LP | 8,806,838 | $359,759,332 | 5.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 517,734 | $21,149,434 | 4.99% |
| Propel Bio Management, LLC | 178,500 | $7,291,725 | 4.73% |
| Boxer Capital, LLC | 1,727,388 | $70,563,800 | 3.72% |
| Avoro Capital Advisors LLC | 6,505,000 | $265,729,250 | 3.54% |
| RA Capital Management | 5,400,408 | $220,606,667 | 2.92% |
| EAM Global Investors LLC | 116,615 | $4,763,723 | 1.07% |